Developmental pharmacology--drug disposition, action, and therapy in infants and children.
about
Beta-blockers for congestive heart failure in childrenWITHDRAWN: Diclofenac for acute pain in children.Diclofenac for acute pain in childrenBeta-blockers for congestive heart failure in childrenBeta blockers for congestive heart failure in childrenDiclofenac for acute pain in childrenInnovative clinical trial design for pediatric therapeuticsLearning Lessons from Adverse Drug Reactions in ChildrenParacetamol as a toxic substance for children: aspects of legislation in selected countriesCaffeine therapy in preterm infantsCharacteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic reviewDevelopment of biomarkers to optimize pediatric patient management: what makes children different?Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatricsAlcohol and breastfeedingDevelopmental pharmacokinetics in pediatric populationsClinical pharmacology of midazolam in neonates and children: effect of disease-a reviewEducational paper: do we need neonatal clinical pharmacologists?Neonatal drug therapy: The first frontier of therapeutics for childrenFluconazole pharmacokinetics and safety in premature infantsPersistent pharmacokinetic challenges to pediatric drug developmentStrategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UsePharmacogenomics in Pediatric Patients: Towards Personalized MedicinePediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunitiesChildren with multiple sclerosis should not become therapeutic hostagesNeonatal pain management: still in search for the Holy GrailPaediatric pharmacokinetics and drug dosesThe Safety of Drug Therapy in ChildrenSedation in Critically Ill Children with Respiratory FailureA New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical TrialsPopulation pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patientsChildren are not just small adults: the urgent need for high-quality trial evidence in childrenLife cycle analysis of kidney gene expression in male F344 ratsA Delphi process to optimize quality and performance of drug evaluation in neonatesDeciphering the Developmental Dynamics of the Mouse Liver TranscriptomeDefective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C DiseaseDose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential ApproachTo scale or not to scale: the principles of dose extrapolationThe Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismEarly phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.
P2860
Q24186346-93BCE777-AC71-4F96-9A44-64CD1009E4B9Q24186675-16416B3A-A1DA-4E2E-9A3C-B1708C488684Q24240354-2B015695-1041-4103-B42E-A9061D627234Q24241410-1E43E6CC-5654-4276-9895-FB346B85152CQ24243333-07B652CC-0BF4-4D1D-AE11-DE909F96FAA9Q24246170-DAB0A2A2-4FC2-4D2D-95F1-43C3367BB104Q24635308-5DB1898C-47C0-44EE-AECB-602007D9C0B3Q26740286-291CA987-FE24-48C5-B66A-2E3254AD22F5Q26776262-7F67FEFD-017B-46A6-AD55-F9AF1FBDD764Q26777204-B68ACB60-5B9B-4890-A6FE-E5A8F27F1B25Q26781716-DBBAD524-754A-46BB-9918-590193FFCE30Q26822946-91FE12AB-AFB7-4ACF-B2E3-A552E8FBEC4EQ26853629-B407F707-0814-4A3F-8EB6-4BB34CE50F1DQ26864773-6971EA39-FE2E-4972-8636-4072BB3E5316Q27002933-F98AB0CB-A485-461D-B62D-6A8BEC0444D5Q27006333-24D3980A-FE4D-4EBB-BD2E-30F225521B1CQ27009662-585E7333-1BF3-487A-8C36-0E045D8FED05Q27013749-45A3CD9A-4E2B-4E21-9CAA-3379EA70125BQ27014816-B1C86F95-26ED-4A62-81D6-6EFA222D9B8EQ27023912-7159F930-03C6-4F87-857D-06329196D394Q27024346-156BB7D6-758C-4A47-B4CB-A2A387F0007BQ28068930-B8D9F979-9219-45BC-866B-34614E005FAEQ28071448-AAFCFB52-2335-4765-8EE2-8897A10E1DBCQ28072376-6FBE5355-51A4-490D-8058-1808F845CBC8Q28077271-ECB30227-2424-4F47-9956-6C870CEF2D9CQ28078751-D8BF7E48-4611-49CB-B806-2D7E447EC433Q28078794-981DBC34-839C-490A-97DC-09C1CA8FAB36Q28079478-FEF10531-B75D-4068-B3A1-CD64C70CD5DCQ28080112-167D3EE7-1C69-4891-BD23-1FE117DD18F5Q28084983-83C800D7-DC10-456C-B3F5-77439C59B403Q28272907-7193D94B-1AD5-42E3-B722-AF91B35E5AE1Q28473435-258A7DFB-5582-4D49-A630-FD2674C46110Q28534148-F2CAA8ED-D7EF-44CB-A437-EB6F8376534BQ28542934-AA3DBEE8-B9D7-4BDE-BAC8-1C8CEFE4F914Q28550476-B49E7F3C-4DBA-4EB3-B41E-7A6372B625A1Q28551021-F42C45B6-66CF-4332-BE3A-59F280113151Q28555174-04DB086E-3C02-41E2-9CC5-9FD0F930EBF4Q28751735-F0A5CF7B-25BD-4761-A937-8724273E6BC1Q28822540-FD1105A9-A575-415B-A258-61750D68A6D9Q30234441-CD054D5C-A024-4375-942A-F3C868214B79
P2860
Developmental pharmacology--drug disposition, action, and therapy in infants and children.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Developmental pharmacology--dr ...... erapy in infants and children.
@ast
Developmental pharmacology--dr ...... erapy in infants and children.
@en
Developmental pharmacology--dr ...... erapy in infants and children.
@nl
type
label
Developmental pharmacology--dr ...... erapy in infants and children.
@ast
Developmental pharmacology--dr ...... erapy in infants and children.
@en
Developmental pharmacology--dr ...... erapy in infants and children.
@nl
prefLabel
Developmental pharmacology--dr ...... erapy in infants and children.
@ast
Developmental pharmacology--dr ...... erapy in infants and children.
@en
Developmental pharmacology--dr ...... erapy in infants and children.
@nl
P2093
P356
P1476
Developmental pharmacology--dr ...... erapy in infants and children.
@en
P2093
Douglas L Blowey
Gregory L Kearns
J Steven Leeder
Ralph E Kauffman
Sarah W Alander
Susan M Abdel-Rahman
P304
P356
10.1056/NEJMRA035092
P407
P577
2003-09-01T00:00:00Z